Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Abayomi B. Ogundele"'
Publikováno v:
Clinical Ophthalmology, Vol 2010, Iss default, Pp 649-652 (2010)
Abayomi B Ogundele, David Earnest, Marsha A McLaughlinAlcon Research, Limited, Fort Worth, TX, USAObjective: The objective of this in vivo study was to compare the incidence of vasodilation in guinea pigs following topical administration of bimatopro
Externí odkaz:
https://doaj.org/article/118b2ef43afc4c7ab3a84fe192c82053
Publikováno v:
Clinical Ophthalmology, Vol 2010, Iss default, Pp 77-80 (2010)
Abayomi B Ogundele, Guangming Li, Joel J EllisAlcon Research, Ltd., Fort Worth, TX, USAIntroduction: The purpose of this study was to examine and compare the conjunctival irritation (congestion, swelling, and discharge) of topical bimatoprost ophthal
Externí odkaz:
https://doaj.org/article/a68abd52cfdb43ebb358af83881faefc
Autor:
John H. Wilton, David E. Martin, Karl Salzwedel, Alan Forrest, Patrick F. Smith, Judy Doto, Abayomi B. Ogundele, Graham P. Allaway
Publikováno v:
Antimicrobial Agents and Chemotherapy. 51:3574-3581
Bevirimat [3-O-(3,3-dimethylsuccinyl)betulinic acid] is the first in a new class of anti-human immunodeficiency virus (HIV) drugs that inhibit viral maturation by specifically blocking cleavage of the Gag capsid (CA) precursor, CA-SP1, to mature CA p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d7191356544a2063e8aea1a41a9ad9a
https://doi.org/10.1128/aac.00152-07
https://doi.org/10.1128/aac.00152-07
Autor:
Patrick F. Smith, Petrie M. Rainey, Abayomi B. Ogundele, David E. Moody, Patricia Pade, Gene D. Morse, Anika Alvanzo, Peter Jatlow, Gerald Friedland, Jennifer Baker, Elinore F. McCance-Katz
Publikováno v:
Clinical Infectious Diseases. 43:S224-S234
This study examined drug interactions between buprenorphine, an opioid partial agonist medication used in the treatment of opioid dependence, and the nonnucleoside reverse-transcriptase inhibitors (NNRTIs) efavirenz (EFV) and delavirdine (DLV). Opioi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1f16b357f37dbca633557e48fe005f0
https://doi.org/10.1086/508187
https://doi.org/10.1086/508187
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 52:255-259
Our objective was to evaluate and compare the in vitro activity of daptomycin, linezolid, and quinupristin/dalfopristin against clinical bloodstream isolates of Gram-positive pathogens from a large cancer center in the Northeastern United States. Min
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4a9c200094098a0d3e9de6882684536
https://doi.org/10.1016/j.diagmicrobio.2005.02.015
https://doi.org/10.1016/j.diagmicrobio.2005.02.015
Publikováno v:
American Journal of Health-System Pharmacy. 62:834-837
Anidulafungin (Vicuron Pharmaceuticals, King of Prussia, PA), a novel investigational antifungal, is in a unique molecular class known as echinocandins.[1][1] Anidulafungin is a broad-spectrum antifungal and has activity against strains resistant to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33129ee05b4937c1d72bc8d35eb86520
https://doi.org/10.1093/ajhp/62.8.834
https://doi.org/10.1093/ajhp/62.8.834
Publikováno v:
American Journal of Health-System Pharmacy. 61:2289-2293
PURPOSE: The physical compatibility of pemetrexed disodium with selected other drugs during simulated Y-site injection was studied. METHODS: A 5 mL sample of pemetrexed disodium 20 mg/mL in 0.9% sodium chloride injection was combined with 5 mL of a s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70fb0b51d36f02cb1ff3cb8c71b91fa2
https://doi.org/10.1093/ajhp/61.21.2289
https://doi.org/10.1093/ajhp/61.21.2289
Publikováno v:
Journal of Oncology Pharmacy Practice. 8:33-37
The physical compatibility of oxaliplatin (Eloxatin, Sanofi-Synthelabo, Malvern, PA) with 58 selected other drugs during simulated Y-site injection was evaluated by visual observation, turbidity measurement, and electronic particle content assessment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cab8e82ee3837f1554e7c9004534dc37
https://doi.org/10.1191/1078155202jp088oa
https://doi.org/10.1191/1078155202jp088oa
Autor:
Patrick F. Smith, Gene D. Morse, Charles S. Berenson, Ellana Eberhardt, Abayomi B. Ogundele, Desiree L Tomilo, Robin DiFrancesco, Edward M. Bednarczyk
Publikováno v:
Pharmacotherapy. 26(3)
Study Objective. To determine whether the pharmacokinetics of atazanavir, a protease inhibitor used to treat human immunodeficiency virus (HIV) infection, are altered by its coadministration with lansoprazole, a proton pump inhibitor. Design. Single-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fb77b4c61562f7b6cfc95a608b88f3a
https://pubmed.ncbi.nlm.nih.gov/16503713
https://pubmed.ncbi.nlm.nih.gov/16503713
Autor:
Abayomi B Ogundele, Delshalonda S Ingram, Christopher A Saenz, Lawrence A. Trissel, Joseph A. Gentempo
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 60(18)
A benchmark contamination rate for prefilled syringe compounding was determined by using a medium-fill-simulation method. One thousand thirty-five 1-mL tuberculin syringes were aseptically filled with 0.9 mL of sterile soybean-casein digest medium an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::333a95d1af6e8822b18790d071b36620
https://pubmed.ncbi.nlm.nih.gov/14521036
https://pubmed.ncbi.nlm.nih.gov/14521036